Kalvelage, Christina <br/><br/>
Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial.  [electronic resource] 

 -  Trials  Mar 2019 
 - 156 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1745-6215 
<br/><br/><label>Standard No.: </label>10.1186/s13063-019-3244-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--therapeutic use<br/>Austria<br/>Biomarkers--blood<br/>Clinical Decision-Making<br/>Germany<br/>Humans<br/>Immunoglobulin A--administration & dosage<br/>Immunoglobulin G--administration & dosage<br/>Immunoglobulin M--administration & dosage<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunotherapy--adverse effects<br/>Infusions, Intravenous<br/>Multicenter Studies as Topic<br/>Patient Selection<br/>Peritonitis--diagnosis<br/>Precision Medicine--adverse effects<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Sepsis--diagnosis<br/>Time Factors<br/>Treatment Outcome